NUVL - CIK 0001861560
The table below shows Nuvalent, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $306.97M | $217.77M | $113.24M | $63.73M | $35.56M | $15.40M |
| SG&A | $107.34M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $62.59M |
| $36.25M |
| $22.38M |
| $10.26M |
| $1.50M |
| Operating income | -$414.31M | -$280.37M | -$149.49M | -$86.11M | -$45.82M | -$16.91M |
| Income tax | $585.00K | $764.00K | $0.00 | $0.00 | - | - |
| Net income | -$425.40M | -$260.76M | -$126.22M | -$81.85M | -$46.34M | -$14.56M |
| EPS (diluted) | -$5.85 | -$3.93 | -$2.17 | -$1.65 | -$2.13 | -$5.08 |